Analysis of the FOURIER trial shows that evolocumab provides greater MACE risk reduction in patients with higher BMI and stable ASCVD.

In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients who have no evidence of calcium in ...

Check this list to ensure you aren't risking a serious infection or a medical emergency by using expired goods.

Data from the ORBITA-2 randomized, placebo-controlled trial emphasize that patient age alone should not be the deciding ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

Total net revenue of $15.2 million Adjusted EBITDA1 of $ (0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) ...

Total net revenue of $15.2 millionAdjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments$30.0 million cash balance at December 31, 2025Company launched EXXUA (gepirone) extended-r ...

Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating ERLEADA® without docetaxel ...

DENVER, CO / / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous ...

In today’s time, Wi-Fi is a necessity for almost every household that needs internet for calling, texting, working from home, as well as for entertainment. But having Wi-Fi issues is also common – you ...

Objectives Female sex and anticitrullinated protein antibodies (ACPA) are associated with higher disease activity in ...